Targeting CD205 with the antibody drug conjugate MEN1309/OBT076 is an active new therapeutic strategy in lymphoma models.

Haematologica · 2020 · PMC7604571 · PMID 33131247

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

highly significantP <0.01actually significant

MEN1309/OBT076 at 5 mg/kg eradicated tumors in all mice with a single dose, highlighted by highly significant differences in tumor volume versus control mice (D7, D21, D28; P <0.01).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.